# Evaluation of Intranasal Naltrexone and Naloxone

> **NCT03851731** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 12 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Naloxone
- **DRUG:** Naltrexol

## Key facts

- **NCT ID:** NCT03851731
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-05
- **Primary completion:** 2015-11-07
- **Final completion:** 2015-11-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851731, "Evaluation of Intranasal Naltrexone and Naloxone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03851731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*